Indexed with PubMed and Science Citation Index (E) 
Users online: 3033 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
    Next article
    Previous article
    Table of Contents

    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded1    
    Comments [Add]    

Recommend this journal


Year : 1996  |  Volume : 62  |  Issue : 1  |  Page : 22--23

Oral psoralens vs injection placental extract plus oral psoralens in Vitiligo

Department of Dermatology and Venereology, Government Medical College, Patiala, India

Correspondence Address:
Adarsh Chopra
27, Bank Colony, Patiala - 147001
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 20947959

Rights and PermissionsRights and Permissions

One hundred patients with vitiligo were enrolled from out patient department from the year 1990-91 for screening the therapeutic effect of injection placental extract (Placentrex). Patients were divided into two groups of 50 each, age and sex matched and were given two different regimens of treatment. In Regimen-I, patients were given oral psoralens followed by sun exposure after 2 hours and then application of topical betamethasone-17 valerate. In Regimen-II patients were given treatment as in regimen-I along with injection of placental extract. It was found that initial response rate of Regimen-II therapy was 36% higher than Regimen-I whereas total efficacy of R-II was 20% higher than R-I.


Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow